1. Home
  2. BIO vs FCN Comparison

BIO vs FCN Comparison

Compare BIO & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • FCN
  • Stock Information
  • Founded
  • BIO 1952
  • FCN 1982
  • Country
  • BIO United States
  • FCN United States
  • Employees
  • BIO N/A
  • FCN N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • FCN Professional Services
  • Sector
  • BIO Industrials
  • FCN Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • FCN Nasdaq
  • Market Cap
  • BIO 6.9B
  • FCN 5.9B
  • IPO Year
  • BIO N/A
  • FCN 1996
  • Fundamental
  • Price
  • BIO $240.46
  • FCN $162.84
  • Analyst Decision
  • BIO Strong Buy
  • FCN Hold
  • Analyst Count
  • BIO 4
  • FCN 2
  • Target Price
  • BIO $396.50
  • FCN $175.50
  • AVG Volume (30 Days)
  • BIO 391.3K
  • FCN 467.7K
  • Earning Date
  • BIO 05-01-2025
  • FCN 04-24-2025
  • Dividend Yield
  • BIO N/A
  • FCN N/A
  • EPS Growth
  • BIO N/A
  • FCN N/A
  • EPS
  • BIO N/A
  • FCN 7.32
  • Revenue
  • BIO $2,566,500,000.00
  • FCN $3,668,381,000.00
  • Revenue This Year
  • BIO $0.88
  • FCN $1.36
  • Revenue Next Year
  • BIO $4.44
  • FCN $6.38
  • P/E Ratio
  • BIO N/A
  • FCN $22.22
  • Revenue Growth
  • BIO N/A
  • FCN 1.59
  • 52 Week Low
  • BIO $215.38
  • FCN $151.75
  • 52 Week High
  • BIO $387.99
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • BIO 43.98
  • FCN 47.37
  • Support Level
  • BIO $232.53
  • FCN $163.01
  • Resistance Level
  • BIO $260.00
  • FCN $172.29
  • Average True Range (ATR)
  • BIO 12.47
  • FCN 4.99
  • MACD
  • BIO 1.94
  • FCN 0.64
  • Stochastic Oscillator
  • BIO 47.20
  • FCN 53.99

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: